ICU Medical will present at the J.P. Morgan Healthcare Conference on January 14, 2026, in San Francisco.
Quiver AI Summary
ICU Medical, Inc. has announced that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco from January 12-15, 2026, with their presentation scheduled for January 14 at 1:30 p.m. PT. During the conference, management will also engage in one-on-one meetings. The presentation will be available via live webcast on the company's website, with a replay option following the event. ICU Medical specializes in infusion systems and critical care products, serving various healthcare settings. The company is based in San Clemente, California, and aims to deliver quality and innovative healthcare solutions globally.
Potential Positives
- ICU Medical will present at the prestigious 44th Annual J.P. Morgan Healthcare Conference, enhancing its visibility and credibility in the healthcare sector.
- The company’s participation in one-on-one meetings indicates engagement with key investors, potentially fostering stronger relationships and support.
- The live webcast of the presentation allows for broad accessibility, potentially reaching a wider audience and attracting investor interest.
Potential Negatives
- None
FAQ
When is ICU Medical presenting at the J.P. Morgan Healthcare Conference?
ICU Medical will present on Wednesday, January 14, 2026, at 1:30 p.m. PT.
How can I access the live webcast of the presentation?
The live webcast can be accessed on ICU Medical's website under the Investors tab and Event Calendar.
Will the presentation be available for replay?
Yes, the presentation will also be available for replay after the live event.
What is ICU Medical known for?
ICU Medical is a leader in infusion systems and critical care products for hospitals and home care settings.
Where is ICU Medical headquartered?
ICU Medical is headquartered in San Clemente, California.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ICUI Insider Trading Activity
$ICUI insiders have traded $ICUI stock on the open market 7 times in the past 6 months. Of those trades, 4 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ICUI stock by insiders over the last 6 months:
- VIVEK JAIN (Chairman and CEO) has made 2 purchases buying 21,929 shares for an estimated $2,474,374 and 0 sales.
- DANIEL WOOLSON (VP, GM-Infusion Capital) sold 2,897 shares for an estimated $441,364
- ELISHA W FINNEY sold 1,285 shares for an estimated $180,439
- DAVID C. GREENBERG has made 2 purchases buying 1,200 shares for an estimated $151,698 and 0 sales.
- VIRGINIA RUTH SANZONE (VP, General Counsel) sold 930 shares for an estimated $132,380
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ICUI Revenue
$ICUI had revenues of $537M in Q3 2025. This is a decrease of -8.85% from the same period in the prior year.
You can track ICUI financials on Quiver Quantitative's ICUI stock page.
$ICUI Hedge Fund Activity
We have seen 135 institutional investors add shares of $ICUI stock to their portfolio, and 143 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 690,694 shares (+173.4%) to their portfolio in Q3 2025, for an estimated $82,855,652
- POINT72 ASSET MANAGEMENT, L.P. removed 329,615 shares (-86.4%) from their portfolio in Q3 2025, for an estimated $39,540,615
- UBS GROUP AG added 272,782 shares (+239.8%) to their portfolio in Q3 2025, for an estimated $32,722,928
- AMERIPRISE FINANCIAL INC added 203,746 shares (+34.0%) to their portfolio in Q3 2025, for an estimated $24,441,370
- NITORUM CAPITAL, L.P. added 197,906 shares (+117.6%) to their portfolio in Q3 2025, for an estimated $23,740,803
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 176,505 shares (-95.9%) from their portfolio in Q3 2025, for an estimated $21,173,539
- SCHRODER INVESTMENT MANAGEMENT GROUP added 160,380 shares (+25.2%) to their portfolio in Q3 2025, for an estimated $19,239,184
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ICUI Analyst Ratings
Wall Street analysts have issued reports on $ICUI in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 11/07/2025
- Keybanc issued a "Overweight" rating on 11/07/2025
- Raymond James issued a "Strong Buy" rating on 08/08/2025
To track analyst ratings and price targets for $ICUI, check out Quiver Quantitative's $ICUI forecast page.
$ICUI Price Targets
Multiple analysts have issued price targets for $ICUI recently. We have seen 3 analysts offer price targets for $ICUI in the last 6 months, with a median target of $175.0.
Here are some recent targets:
- Jason Bednar from Piper Sandler set a target price of $172.0 on 11/07/2025
- Brett Fishbin from Keybanc set a target price of $175.0 on 11/07/2025
- Jayson Bedford from Raymond James set a target price of $180.0 on 08/08/2025
Full Release
SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 12-15, 2026. ICU Medical’s presentation will be on Wednesday, January 14, 2026 at 1:30 p.m. PT (4:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 14, 2026.
The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com , clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com .
CONTACT:
ICU Medical
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.
